
Joshua Armenia, PhD, Memorial Sloan Kettering Cancer Center, discusses the significance of analyzing mutated genes in prostate cancer.

Your AI-Trained Oncology Knowledge Connection!


Published: April 25th 2017 | Updated:

Published: February 17th 2017 | Updated: